How bacteria adhere to cells: Basis for the development of a new class of antibiotics
The adhesion of bacteria to host cells is always the first and one of the decisivesteps in the development of infectious diseases. The purpose of this adhesion by infectious pathogens is first to colonize the host organism (i.e., the human body), and then to trigger an infection, which in the worst case can end fatally. Precise understanding of the bacteria’s adhesion to host cells is a key to finding therapeutic alternatives that block this critical interaction in the earliest possible stage of an infection.
First author of the study: Diana Jaqueline Vaca, Institute of Medical Microbiology and Hospital Hygiene at University Hospital Frankfurt.
University Hospital Frankfurt
Critical interaction with the human protein fibronectin
In collaboration with other researchers, scientists from University Hospital Frankfurt and Goethe University Frankfurt have now explained the exact bacterial adhesion mechanism using the human-pathogenic bacterium Bartonella henselae. This pathogen causes “cat-scratch disease”, a disease transmitted from animals to humans. In an international collaborative project led by the Frankfurt research group headed by Professor Volkhard Kempf, the bacterial adhesion mechanism was deciphered with the help of a combination of in-vitro adhesion tests and high-throughput proteomics. Proteomics is the study of all the proteins present in a cell or a complex organism.
The scientists have shed light on a key mechanism: the bacterial adhesion to the host cells can be traced back to the interaction of a certain class of adhesins – called “trimeric autotransporter adhesins” – with fibronectin, a protein often found in human tissue. Adhesins are components on the surface of bacteria which enable the pathogen to adhere to the host’s biological structures. Homologues of the adhesin identified here as critical are also present in many other human-pathogenic bacteria, such as the multi-resistant Acinetobacter baumannii, which the World Health Organization (WHO) has classified as the top priority for research into new antibiotics.
State-of-the-art protein analytics were used to visualize the exact points of interaction between the proteins. In addition, it was possible to show that experimental blocking of these processes almost entirely prevents bacterial adhesion. Therapeutic approaches that aim to prevent bacterial adhesion in this way could represent a promising treatment alternative as a new class of antibiotics (known as “anti-ligands”) in the constantly growing domain of multi-resistant bacteria.
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Analytica conference 2020 for the first time virtual - Topics in focus: Antibiotic resistance and the “laboratory of the future”
Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person
The race is on for new lithium ion batteries - Battery consortium headed by BASF receives € 21 million sponsorship from German Ministry of Education and Research
Antibiotic resistance testing no longer impeded by time - Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs
A new way to stimulate cellular recycling process
Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased
New insights into the function of a risk factor for Alzheimer’s disease - Researchers decipher the structure-function relationship of the multifunctional protein clusterin for the first time
Rigaku opens Rigaku Technology Center Taiwan - Advancing regional growth through engineering and collaboration in Taiwan and beyond
Multiplexed Morse signals from cells
Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease
Closing in on the elusive rotational-vibrational CH5+ spectra
